- Trials with a EudraCT protocol (12)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (8)
12 result(s) found for: Plants.
Displaying page 1 of 1.
EudraCT Number: 2012-001651-39 | Sponsor Protocol Number: BIGRADE-IHR-12 | Start Date*: 2012-11-14 | ||||||||||||||||
Sponsor Name:LOFARMA | ||||||||||||||||||
Full Title: In-vivo biological standardization of Dermatophagoides, Betulaceae and Graminaceae extracts for the determination of the biological activity in HEP units | ||||||||||||||||||
Medical condition: Respiratory allergopathy | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2011-004522-10 | Sponsor Protocol Number: Lais-Amb-11 | Start Date*: 2012-05-06 | |||||||||||
Sponsor Name:LOFARMA | |||||||||||||
Full Title: Study on the efficacy and safety of three different doses of Lais Ambrosia tablets in patients with allergic rhinoconjunctivitis to pollen of Ambrosia | |||||||||||||
Medical condition: rhinoconjunctivitis allergic to ragweed pollen | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-014923-22 | Sponsor Protocol Number: GT-23 | Start Date*: 2009-11-27 | |||||||||||
Sponsor Name:ALK-ABELLO` | |||||||||||||
Full Title: A phase IIIB trial investigating 3-year treatment efficacy, tolerability and safety of Grazax in children aged 5-18 years with grass pollen induced rhinoconjunctivitis with/without controlled con... | |||||||||||||
Medical condition: children from 5 to 18 years with grass pollen induced rhinoconjunctivitis with/without controlled asthma | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-005713-35 | Sponsor Protocol Number: RPE 04 | Start Date*: 2007-03-20 |
Sponsor Name:Curalogic A/S | ||
Full Title: A RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF ORAL MICROENCAPSULATED RAGWEED POLLEN EXTRACT ADMINISTERED PRIOR TO AND DURING THE RAGWEED ... | ||
Medical condition: Treatment of seasonal allergic rhinitis to ragweed pollen. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: HU (Completed) IT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2005-004013-15 | Sponsor Protocol Number: 920'110 | Start Date*: 2006-01-11 |
Sponsor Name:Bioforce AG | ||
Full Title: Effects of Echinaforce®-treatment on the response of ex vivo stimulated blood cells | ||
Medical condition: Healthy volunteers | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-004502-26 | Sponsor Protocol Number: DL/HL/09/18 | Start Date*: 2019-07-18 | ||||||||||||||||||||||||||||||||||||
Sponsor Name:Przedsiębiorstwo Produkcji Farmaceutycznej (P.P.F.)HASCO-LEK S.A. | ||||||||||||||||||||||||||||||||||||||
Full Title: "Randomized, double-blind, cross-over efficacy and safety study based on the pharmacodynamic model of topical use of the new combination gel containing diphenhydramine hydrochloride 20 mg/g and lid... | ||||||||||||||||||||||||||||||||||||||
Medical condition: Skin inflamatory and allergic lesions inducted by insects bites (i.e. mosquitos) and after contact with plants (i.e.urtica). Decreasing redness, edema, papular urticaria, analgesic, antipriuritic a... | ||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||
Trial protocol: PL (Completed) | ||||||||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2020-001536-98 | Sponsor Protocol Number: PREPSARS | Start Date*: 2020-04-18 |
Sponsor Name:HOSPITAL UNIVERSITARI MÚTUA TERRASSA | ||
Full Title: Prophylaxis of COVID-19 infection with hydroxychloroquine in healthcare personnel with high risk of infection. | ||
Medical condition: COVID-19 infection | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2006-007053-51 | Sponsor Protocol Number: 003/APR06 | Start Date*: 2007-07-02 | ||||||||||||||||
Sponsor Name:Gloucestershire Hospitals NHS Foundation Trust | ||||||||||||||||||
Full Title: Diamorphine or alfentanil for subcutaneous use in hospice in-patients | ||||||||||||||||||
Medical condition: Palliative Care | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2005-004525-26 | Sponsor Protocol Number: DAD-Study | Start Date*: 2006-03-17 | |||||||||||
Sponsor Name:Ruhr Universität Bochum | |||||||||||||
Full Title: Cognitive behavioural therapy vs. sertraline in patients with depression and poorly controlled diabetes mellitus: A randomized controlled trial | |||||||||||||
Medical condition: Patients with insulin-treated type 1 or type 2 diabetes mellitus with depression and HbA1c-value >7,5% ICD E14.90 with F32 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-004719-28 | Sponsor Protocol Number: D8850C00003 | Start Date*: 2020-11-20 | |||||||||||
Sponsor Name:AstraZeneca AB | |||||||||||||
Full Title: A Phase III Randomized, Double-blind, Placebo-controlled, Multi-center Study in Adults to Determine the Safety and Efficacy of AZD7442, a Combination Product of Two Monoclonal Antibodies (AZD8895 a... | |||||||||||||
Medical condition: COVID-19 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-000585-30 | Sponsor Protocol Number: I16016 | Start Date*: 2017-12-13 | ||||||||||||||||
Sponsor Name:CHU de Limoges | ||||||||||||||||||
Full Title: Pilot study, single-blind, candesartan versus usual care of peripheral neuropathy development induced by vincristine (PNIV) in patients treated for lymphoma B. | ||||||||||||||||||
Medical condition: peripheral neuropathy | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: FR (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2020-004356-16 | Sponsor Protocol Number: D8850C00002 | Start Date*: 2020-11-18 | |||||||||||
Sponsor Name:AstraZeneca AB | |||||||||||||
Full Title: A Phase III Randomized, Double-blind, Placebo-controlled, Multi-center Study in Adults to Determine the Safety and Efficacy of AZD7442, a Combination Product of Two Monoclonal Antibodies (AZD8895 a... | |||||||||||||
Medical condition: COVID-19 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) BE (Completed) FR (Completed) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.